Get the Daily Brief
Latest Biotech News
Radiopharmaceutical Combo Extends Control in Recurrent Prostate Cancer
A landmark Phase II trial, LUNAR, reveals that combining PSMA-targeted radioligand therapy with stereotactic body radiation therapy (SBRT) more than doubles progression-free survival in...
Uniquely Engineered Macrophages Enhance Melanoma Immunotherapy
Researchers have engineered macrophages to effectively target melanoma cells, advancing immunotherapy strategies against one of the deadliest skin cancers. This novel cell engineering approach...
Low-Dose Radiation Therapy Emerges as Pain Relief for Knee Osteoarthritis
A randomized controlled trial in South Korea has demonstrated that a single course of low-dose radiation therapy significantly alleviates pain in patients with mild to moderate knee...
Sanofi Ventures Expands with $625 Million Injection to Fuel Early-Stage Biotechs
Sanofi Ventures has secured an additional $625 million, pushing total assets past $1.4 billion to invest in breakthrough biotech startups. The funding targets innovative therapies across...
Thyme Care Raises $97 Million to Advance Value-Based Oncology Management
Thyme Care completed a $97 million Series D funding round featuring major investors such as CVS Health Ventures, Foresite Capital, and Humana. The company focuses on delivering value-based care...
AI-Powered Microdevice Enables Rapid Single-Cell Delivery and Analysis
A newly developed parallel microdevice leverages artificial intelligence to facilitate high-throughput intracellular delivery and rapid quantitative single-cell analysis. This technology aims to...
Tiny Lung-Cell-Based Robots Designed for Targeted Therapeutic Delivery
Carnegie Mellon University researchers introduced ‘AggreBots’ — microscale living robots engineered from human lung cells. These biological robots exhibit customizable motility, promising future...
Metabolic Drug Tirzepatide Demonstrates Broader Weight Management Benefits
A comprehensive meta-analysis confirms tirzepatide, a dual GIP/GLP-1 receptor agonist, provides effective weight reduction across populations with and without diabetes. The systematic review...
Electrical Stimulation Therapies Evaluated for Diabetic Ulcer Treatment
A network meta-analysis compares the safety and efficacy of various electrical stimulation modalities in treating diabetic foot ulcers. This comprehensive review published in Advances in Therapy...
Thyme Care’s $97 Million Series D Fuels Value-Based Cancer Care Expansion
Thyme Care secured $97 million in its latest Series D funding round led by major healthcare investors including CVS Health Ventures, Foresite Capital, Morgan Health, and Humana. This investment...
AI Advances in Clinical Research and Healthcare Trust Under Scrutiny
Emerging studies highlight both the potential and challenges of artificial intelligence (AI) in healthcare. New AI-powered platforms like InfEHR use deep geometric learning to enhance clinical...
Novel Engineered Macrophage Therapies and Glycan-Targeting Immunotherapy in Cancer
Innovative immunotherapeutic strategies show promise against difficult-to-treat cancers. Researchers engineered macrophages to target melanoma more precisely, advancing cell-based cancer...
Pediatric Asthma Clinical Trials Show Combination Inhaler Halves Attack Rates
A recent landmark clinical trial published in The Lancet demonstrates that combination inhalers significantly reduce asthma attacks in children by nearly 50%, outperforming traditional...
Biotech Investment Surges with Nine-Figure Rounds and New Funds
Leading biotech firms including MBX and uniQure have recently secured nine-figure funding rounds, reflecting robust investor confidence. Mission BioCapital announced a $134 million raise for its...
Breakthroughs in Radiation Oncology Presented at ASTRO 2025 Conference
Researchers from multiple institutions, including UCLA and the University of Cincinnati, unveiled advances in targeted radioactive therapies for cancers such as recurrent prostate, head and neck,...
FDA Approvals and Legal Developments Impact Biopharma Landscape
Crinetics Pharmaceuticals gained FDA approval for Palsonify, the first oral first-line therapy for acromegaly, positioned to compete with established injectable treatments from Novartis and Ipsen....
Carnegie Mellon’s ‘AggreBots’ and Advances in Biobot Engineering
Carnegie Mellon University researchers have created microscale living robots, termed AggreBots, engineered from human lung cells. These custom biobots represent a novel convergence of tissue...
Significant Progress in Kidney Cancer Epidemiology and Prognostic Modeling with AI
New studies forecast a doubling in global kidney cancer incidence by 2050, driven by modifiable risk factors. Concurrently, machine learning models are enhancing predictions of liver failure in...
Crinetics’ Palsonify FDA Nod Sets Stage to Rival Novartis, Ipsen in Acromegaly Therapy
Crinetics Pharmaceuticals secured FDA approval for Palsonify (paltusotine), the first oral once-daily treatment for acromegaly targeting patients with inadequate surgical response or inoperable...
Lilly Secures FDA Approval for Late-Stage Breast Cancer SERD Imlunestrant
Eli Lilly’s oral selective estrogen receptor degrader (SERD), imlunestrant (Inluriyo), has been approved by the FDA for adults with estrogen receptor-positive, HER2-negative ESR1-mutated advanced...